Zobrazeno 1 - 10
of 281
pro vyhledávání: ''
Autor:
S. Artale, Martina Torchio, Lorenza Bertù, Monica Giordano, Luca Galli, Marco Danova, Olga Nigro, Graziella Pinotti, Francesco Dentali, Marco Bregni, Andrea Antonuzzo, Sabrina Barzaghi, Elena Bolzacchini
Publikováno v:
Tumori Journal. 108:502-509
Background: Hemochrome parameters at the diagnosis of metastatic renal cell carcinoma (mRCC) and the development of macrocytosis during sunitinib therapy are considered prognostic. Objective: To evaluate the prognostic role of hematologic parameters
Autor:
Fabiola Paiar, Riccardo Morganti, Emanuele Neri, Angiolo Gadducci, Michela Gabelloni, Roberto Mattioni, Francesca Orlandi, Amelia Barcellini, Sabina Giusti, Concetta Laliscia
Publikováno v:
Tumori Journal. 108:376-385
Objective: To assess prognostic factors by analyzing clinical and radiomic data of patients with locally advanced cervical cancer (LACC) treated with definitive concurrent cisplatin-based chemoradiotherapy (CCRT) using magnetic resonance imaging (MRI
Publikováno v:
Tumori Journal. 108:258-262
Introduction: Lung cancer is the most common cause of cancer-related death in the world. Changes in the treatment of metastatic lung cancer in recent years have made targetable mutations gain importance. MET alteration is one of these driver mutation
Autor:
Michela Casanova, Tommaso Giandini, Livellara Virginia, Andrea C. Ferrari, Emilia Pecori, Luca Bergamaschi, Giovanna Sironi, Barbara Diletto, Stefano Chiaravalli, Ombretta Alessandro
Publikováno v:
Tumori Journal. 108:93-97
This study reports the treatment feasibility and efficacy of a novel multiagent intensive treatment program for young patients with desmoplastic small round cell tumor. This small series includes three patients and should be seen as a first suggestio
Autor:
Giulia Bianchi, Emma Zattarin, Francesca Ligorio, Federico Nichetti, Filippo de Braud, Giuseppe Capri
Publikováno v:
Tumori Journal. 107:NP15-NP19
Introduction: Breast cancer in men is less common than in women and treatment recommendations are often derived from clinical trials exclusively involving women. Data on efficacy of CDK 4/6 inhibitors, which are the mainstay of treatment for hormone
Autor:
Francesca Corti, Giovanni Fucà, Filippo Pagani, Alessandra Raimondi, Rosalba Miceli, Filippo de Braud, Giovanni Randon, Paolo Manca, Chiara Cremolini, Michele Prisciandaro, Filippo Pietrantonio
Publikováno v:
Tumori Journal. 107:353-359
Background: The RECOURSE trial (Study of TAS-102 in Patients With Metastatic Colorectal Cancer Refractory to Standard Chemotherapies) demonstrated an overall survival (OS) benefit of trifluridine/tipiracil (FTD/TPI) vs placebo in refractory metastati
Autor:
Tiziana Pressiani, Enrico Aitini, Fabiola Cecchi, Gianni Sanna, Daniel V.T. Catenacci, Gerardo Rosati, Lorenza Landi, Hector Soto Parra, Francesca Spada, Yuan Tian, Stefano Tamberi, Elisa Giommoni, Carmine Pinto, Todd Hembrough, Luigi Cavanna, Shankar Sellappan, Antonia Martinetti, Alberto Marchet, Stefania Mosconi, Alberto Zaniboni, Alessandro Pellegrinelli, Rosalba Miceli, Francesca Pucci, Alessandra Raimondi, Paola Bolzoni, Sarit Schwartz, Filippo Pietrantonio, Maurizio Cantore, Salvatore Corallo, Maria Di Bartolomeo
Publikováno v:
Tumori Journal. 107:150-159
Background:No predictive markers for chemotherapy activity have been validated in gastric cancer (GC). The potential value of class III β-tubulin (TUBB3) as biomarker for prognosis and resistance to taxane-based therapy was reported.Methods:We analy
Publikováno v:
Tumori Journal. 107:119-124
Objective: To determine the combined efficacy of piperlongumine and gemcitabine for treatment of KRAS mutant lung cancer. Methods: The cell growth inhibition of piperlongumine, gemcitabine, and piperlongumine plus gemcitabine was measured by Cell Cou
Publikováno v:
Tumori Journal. 106:NP79-NP83
Background: Papillary renal cell carcinoma (pRCC) represents the second most common histologic subtype of renal cell carcinoma and comprises 2 subtypes. Prognosis for type 2 is associated with poor clinical outcome. Current guidelines are based on ph
Autor:
Umut Elboga, Havva Yesil Cinkir
Publikováno v:
Tumori Journal. 106:312-318
Objective: To determine the effect of systemic inflammation indexes and fluorine-18 fluorodeoxyglucose (18FDG) positron emission tomography (PET) metabolic parameters on survival in advanced lung adenocarcinoma. Methods: A total of 133 patients who u